Skip to main content

The influence of 'Tall Man' lettering on errors of visual perception in the recognition of written drug names

Buy Article:

$71.00 + tax (Refund Policy)

Visual errors in the perception of written drug names can reflect orthographic similarity amongst certain names. Drug names are typically printed in lowercase text. 'Tall Man' lettering, the capitalisation of the portions that differ amongst orthographically similar drug names, is employed in the field of medication labelling and prescribing to reduce medication errors by highlighting the area most likely to prevent confusion. The influence of textual format on visual drug name perception was tested amongst healthcare professionals (n = 133) using the Reicher-Wheeler task. Relative to lowercase text, Tall Man lettering improved accuracy in drug name perception. However, an equivalent improvement in accuracy was obtained using entirely uppercase text. Thus, character size may be a key determinant of perceptual accuracy for Tall Man lettering. Specific considerations for the manner in which Tall Man lettering might be best formatted and implemented in practice to reduce medication errors are discussed. Statement of Relevance:Tall Man lettering aims to prevent medication errors by reducing visual confusions amongst orthographically similar drug names. It was found that, compared to lowercase text, Tall Man lettering improved accuracy in drug name perception. Character size appeared to be a key determinant of perceptual accuracy for Tall Man lettering.

Keywords: Tall Man lettering; drug name; medication error; reading; visual perception

Document Type: Research Article

Affiliations: 1: Applied Vision Research Centre, Garendon Wing, Holywell Park, Loughborough University, Leicestershire, UK 2: National Patient Safety Agency, London, UK 3: School of Psychology, University of Nottingham, University Park, Nottingham, UK

Publication date: 01 January 2011

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content